ALTERITY THERAPEUTICS LTD ATHE

Latest FY: 2025 Healthcare Biotechnology
Market Price $4.50
Market Cap $41.07B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑66.3% YoY
$446.29K
3-Yr CAGR: 462.8%
Net Income ↑36.7% YoY
-$12.08M
Net Margin: -2,706.7%
Free Cash Flow ↓-100.0% YoY
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-28.5%
ROA: -26.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ATHE)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2018: Revenue YoY (+51.9%) is identical to Gross Profit YoY (+51.9%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
  • FY 2019: Revenue YoY (-46.0%) is identical to Gross Profit YoY (-46.0%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 0.00%
FY 2017 $0.1M $0.1M $-7.5M 0.00% $0.1M
FY 2018 $0.2M +51.9% $0.2M $-8.3M -9.6% 0.00% $0.2M $0.1M
FY 2019 $0.1M -46.0% $0.1M $-12.3M -49.3% 0.00% $0.1M $0.1M -17.7%
FY 2020 $0.0M -84.2% $0.0M $-13.5M -9.1% 0.00% $0.0M $-0.0M -111.5%
FY 2021 $0.0M +20.8% $0.0M $15.3M +213.8% 0.00% $0.0M $-0.0M +28.7%
FY 2022 $0.0M -87.9% $0.0M $12.8M -16.1% 0.00% $0.0M $-0.1M -846.9%
FY 2023 $0.0M +556.4% $0.0M $13.8M +7.5% 0.00% $0.0M $-0.0M +96.8%
FY 2024 $0.3M +1,533.1% $0.3M $-19.1M -238.2% 0.00% $0.0M $0.0M +154.4%
FY 2025 $0.4M +66.3% $0.4M $-12.1M +36.7% 0.00% -100.0%
$

Valuation

Market Price $4.50
Market Cap $41.07B
Enterprise Value $41.04B
P/E Ratio N/A
P/B Ratio 968.64
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 9,127,370,686
%

Profitability & Margins

Gross Margin 98.61%
Operating Margin -2,706.70%
Net Margin -2,706.70%
Return on Equity (ROE) -28.49%
Return on Assets (ROA) -26.25%
Asset Turnover 0.01x
Revenue 3-Yr CAGR 462.77%
🛡️

Financial Health & Liquidity

Current Ratio 63,129.04
Cash Ratio 238,551.38
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $33.16M
Total Debt N/A
Book Value / Share $0.00
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) N/A
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.00
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $46.03M
Total Liabilities $3.62M
Stockholders' Equity $42.40M
Current Assets $8.77M
Current Liabilities $139.00